IRIS UniCatt

Ciccarese, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 769
NA - Nord America 656
EU - Europa 353
SA - Sud America 199
AF - Africa 25
OC - Oceania 2
Totale 2.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 628
SG - Singapore 298
BR - Brasile 172
CN - Cina 171
VN - Vietnam 94
SE - Svezia 71
IT - Italia 70
IN - India 59
DE - Germania 52
FR - Francia 49
GB - Regno Unito 26
JP - Giappone 26
HK - Hong Kong 21
BD - Bangladesh 19
IE - Irlanda 19
ID - Indonesia 16
MX - Messico 16
PL - Polonia 14
KR - Corea 13
IQ - Iraq 12
RU - Federazione Russa 11
CA - Canada 10
AR - Argentina 8
ZA - Sudafrica 8
EC - Ecuador 7
ES - Italia 7
TR - Turchia 7
FI - Finlandia 6
NL - Olanda 6
EG - Egitto 5
SA - Arabia Saudita 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
VE - Venezuela 4
CL - Cile 3
DZ - Algeria 3
MM - Myanmar 3
PH - Filippine 3
PK - Pakistan 3
AU - Australia 2
CI - Costa d'Avorio 2
CO - Colombia 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 2.004
Salva come PNG Salva come JPEG
Città #
Singapore 144
San Jose 113
Ashburn 81
Chandler 43
Hefei 38
Ho Chi Minh City 38
Hyderabad 35
Beijing 32
Frankfurt am Main 27
Tokyo 25
Los Angeles 24
Hanoi 23
Lauterbourg 22
Hong Kong 20
Dublin 19
São Paulo 19
New York 18
Rome 18
Seoul 13
Jakarta 12
The Dalles 12
Milan 11
Chicago 10
Kent 10
Orem 10
Santa Clara 10
Warsaw 10
Düsseldorf 9
Mexico City 9
Brooklyn 8
Chennai 8
Dallas 7
Johannesburg 7
Boston 6
Denver 6
Dhaka 6
Houston 6
Poplar 6
Porto Alegre 6
Princeton 6
Baghdad 5
Curitiba 5
Da Nang 5
Dearborn 5
Munich 5
Seattle 5
Ankara 4
Atlanta 4
Buffalo 4
Falkenstein 4
Helsinki 4
Jeddah 4
Moscow 4
Nanjing 4
Portsmouth 4
Rio de Janeiro 4
Stockholm 4
Wilmington 4
Amsterdam 3
Belo Horizonte 3
Bexley 3
Cairo 3
Guayaquil 3
Haiphong 3
Hebei 3
Montreal 3
Querétaro 3
Recife 3
Redwood City 3
San Mateo 3
Secaucus 3
Shanghai 3
São Gonçalo 3
Toronto 3
Uberlândia 3
Abidjan 2
Addis Ababa 2
Alghero 2
Amman 2
Berlin 2
Boardman 2
Brescia 2
Bắc Ninh 2
Canaã dos Carajás 2
Cleveland 2
Concord 2
Cruzeiro 2
Dubai 2
Duncan 2
Erbil 2
Greensboro 2
Guaratinguetá 2
Hải Dương 2
Karachi 2
Lappeenranta 2
Ljubljana 2
London 2
Maceió 2
Madrid 2
Medellín 2
Totale 1.106
Salva come PNG Salva come JPEG
Nome #
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 121
Biomarkers of response to advanced prostate cancer therapy 121
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 120
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 120
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 107
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients 104
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 97
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives 96
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 94
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma 94
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations 91
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 90
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 82
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 82
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 80
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis 77
Revising PTEN in the era of immunotherapy: New perspectives for an old story 76
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin 71
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis 70
Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors 70
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 57
Totale 2.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 4 0 3 4 6 0 0 6 1 1 14 6
2022/2023135 26 22 8 12 15 8 9 12 14 1 3 5
2023/202498 6 21 3 11 4 11 4 0 7 3 13 15
2024/2025456 3 1 16 8 6 9 47 17 45 83 103 118
2025/20261.263 199 64 84 200 220 57 178 87 76 88 10 0
Totale 2.040